Compare FFWM & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FFWM | SLP |
|---|---|---|
| Founded | 1990 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.1M | 418.4M |
| IPO Year | 2014 | 1997 |
| Metric | FFWM | SLP |
|---|---|---|
| Price | $6.05 | $19.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $6.17 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 637.5K | 336.1K |
| Earning Date | 01-29-2026 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $159,621,000.00 | $78,676,000.00 |
| Revenue This Year | $166.48 | $2.64 |
| Revenue Next Year | $6.86 | $6.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.55 | 5.70 |
| 52 Week Low | $4.42 | $12.39 |
| 52 Week High | $6.54 | $37.67 |
| Indicator | FFWM | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 46.20 |
| Support Level | $5.89 | $19.50 |
| Resistance Level | $6.28 | $21.01 |
| Average True Range (ATR) | 0.21 | 1.04 |
| MACD | -0.04 | -0.08 |
| Stochastic Oscillator | 18.46 | 61.08 |
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.